Radical pleurectomy and intraoperative photodynamic therapy for malignant pleural mesothelioma.
Ann. Thorac. Surg., May;93(5):1658-65; discussion 1665-7 (2012)
The Case for Combined-Modality Therapy for Limited-Stage Hodgkin's Disease.
Oncologist., 17(8):1006-10 (2012)
Photofrin uptake in the tumor and normal tissues of patients receiving intraperitoneal photodynamic therapy.
Clin. Cancer Res., Sep;12(18):5464-70 (2006)
Intensity-modulated radiation therapy dose prescription, recording, and delivery: patterns of variability among institutions and treatment planning systems.
J. Natl. Cancer Inst., Mar;100(5):300-7 (2008)
Commentary: let the tail wag the dog: the case for radioimmunotherapy of low-grade follicular lymphoma.
Oncologist., Jun;13(6):655-6 (2008)
Some cases of severe normal tissue toxicity can be anticipated with ablated fractionated radiation with appropriate long-term follow-up.
Semin Radiat Oncol., Oct;18(4):229-33 (2008)
Elective nodal irradiation (ENI) vs. involved field radiotherapy (IFRT) for locally advanced non-small cell lung cancer (NSCLC): A comparative analysis of toxicities and clinical outcomes.
Radiother Oncol., May;95(2):178-84 (2010)
Oncologist., 15(4):388-9 (2010)
A phase I study of topical Tempol for the prevention of alopecia induced by whole brain radiotherapy.
Clin. Cancer Res., Oct;10(19):6411-7 (2004)
Short-term and long-term health risks of nuclear-power-plant accidents.
N. Engl. J. Med., Jun;364(24):2334-41 (2011)
Photodynamic therapy and the evolution of a lung-sparing surgical treatment for mesothelioma.
Ann. Thorac. Surg., Jun;91(6):1738-45 (2011)
Patterns of recurrence in patients treated with photodynamic therapy for intraperitoneal carcinomatosis and sarcomatosis.
Int. J. Oncol., Mar;24(3):711-7 (2004)
Broadband reflectance measurements of light penetration, blood oxygenation, hemoglobin concentration, and drug concentration in human intraperitoneal tissues before and after photodynamic therapy.
J Biomed Opt., 10(1):14004 (2005)
Noninvasive monitoring of murine tumor blood flow during and after photodynamic therapy provides early assessment of therapeutic efficacy.
Clin. Cancer Res., May;11(9):3543-52 (2005)
Gemcitabine-induced pericardial effusion and tamponade after unblocked cardiac irradiation.
Leuk. Lymphoma., Sep;46(9):1313-20 (2005)
Updated results of a phase I trial of motexafin lutetium-mediated interstitial photodynamic therapy in patients with locally recurrent prostate cancer.
J. Environ. Pathol. Toxicol. Oncol., 25(1-2):373-87 (2006)
Optical properties of human prostate at 732 nm measured in mediated photodynamic therapy.
Photochem. Photobiol., 81(1):96-105 (2005)
Combined modality therapy for non-small cell lung carcinoma.
Cancer J., 8 Suppl 1:S55-67 (2002)
Photodynamic therapy creates fluence rate-dependent gradients in the intratumoral spatial distribution of oxygen.
Cancer Res., Dec;62(24):7273-9 (2002)
Effect of photosensitizer dose on fluence rate responses to photodynamic therapy.
Photochem. Photobiol., 83(5):1040-8 (2007)
Should randomized clinical trials be required for proton radiotherapy? An alternative view.
J. Clin. Oncol., May;26(15):2438-9 (2008)
Radiotherapy for early-stage Hodgkin's lymphoma: a 21st century perspective and review of multiple randomized clinical trials.
Int. J. Radiat. Oncol. Biol. Phys., Dec;72(5):1472-9 (2008)
In vivo optical properties of normal canine prostate at 732 nm using motexafin lutetium-mediated photodynamic therapy.
Photochem. Photobiol., Jan;77(1):81-8 (2003)
Intensity-modulated radiation therapy: the inverse, the converse, and the perverse.
Semin Radiat Oncol., Jul;12(3):272-81 (2002)